Vaccination

Risk factors for pandemic-related workplace absenteeism among health care workers and the impact of vaccination
S Piel, M A Presotto, R A Jörres, S Karrasch, W Gesierich, J Bullwinkel, K F Rabe, M Hayden, F Kaestner, D Harzheim, B Joves, A T Kempa, A Ghiani, C Neurohr, M Kreuter, F J Herth, F C Trudzinski

European Respiratory Journal Sep 2022, 60 (suppl 66) 2775; DOI: 10.1183/13993003.congress-2022.2775
Evaluation of lung immune response to the BNT162b2 COVID-19 vaccine
D Padawer, M Stolovich-Rain, M Billan, N Berkman, A Rouvinski

European Respiratory Journal Sep 2022, 60 (suppl 66) 2714; DOI: 10.1183/13993003.congress-2022.2714
A 7-year retrospective evaluation of incidence of exacerbations in COPD patients pre and post pneumococcal vaccination. Results from RETRIEVE study.
E Papadopoulou, M Bertoli, A Ginis, S Tryfon

European Respiratory Journal Sep 2022, 60 (suppl 66) 2924; DOI: 10.1183/13993003.congress-2022.2924
A 7-year retrospective evaluation of lung function in COPD patients pre and post pneumococcal vaccination. Results from RETRIEVE study.
E Papadopoulou, M Bertoli, A Ginis, S Tryfon

European Respiratory Journal Sep 2022, 60 (suppl 66) 2917; DOI: 10.1183/13993003.congress-2022.2917
COVID-19: Vaccinated versus unvaccinated or not fully vaccinated patients
A Digalaki, G Hillas, S Koukidou, A Sakellaropoulou, C Kosti, S Chrysikos, K Dimakou

European Respiratory Journal Sep 2022, 60 (suppl 66) 2262; DOI: 10.1183/13993003.congress-2022.2262
Comparison of clinical outcomes between COVID-19 vaccinated and unvaccinated patients admitted to a Respiratory Intensive Care Unit.
F Lionello, G Guarnieri, B Molena, C Giraudo, G Arcaro, S Lococo, F Braccioni, A Achille, C Contessa, F Lugato, F Gallan, A Vianello

European Respiratory Journal Sep 2022, 60 (suppl 66) 2381; DOI: 10.1183/13993003.congress-2022.2381
Covid-19 in lung allograft recipients - better outcomes after vaccination?
M A Oliveira Pinto, J Rodrigues, A S Santos, L Semedo

European Respiratory Journal Sep 2022, 60 (suppl 66) 1471; DOI: 10.1183/13993003.congress-2022.1471
Is it really so important to study humoral immunity to SARS-CoV-2?
Y V Huba, O V Myronenko, O V Plekhanova, H A Garagulya

European Respiratory Journal Sep 2022, 60 (suppl 66) 1733; DOI: 10.1183/13993003.congress-2022.1733
Determinants of antibody responses to primary courses and booster doses of SARS-CoV-2 vaccines in 9,101 UK adults
D A Jolliffe, S E Faustini, H Holt, M Talaei, G Vivaldi, A G Richter, S O Shaheen, A R Martineau

European Respiratory Journal Sep 2022, 60 (suppl 66) 1680; DOI: 10.1183/13993003.congress-2022.1680
Risk factors for breakthrough COVID-19 in 15,804 UK adults after primary and booster doses of SARS-CoV-2 vaccines
G Vivaldi, D A Jolliffe, H Holt, M Talaei, F Tydeman, S O Shaheen, A R Martineau

European Respiratory Journal Sep 2022, 60 (suppl 66) 1700; DOI: 10.1183/13993003.congress-2022.1700

Main menu

User menu

Search

Vaccination

Pages

Contact us